Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)

BMC Nephrology

Volumn 7, Issue , 2006, Pages

  Alexopoulos, Efstathios ^a   Gionanlis, Lazaros ^b   Papayianni, Ekaterini ^a   Kokolina, Elizabeth ^a   Leontsini, Maria ^a   Memmos, Dimitrios ^a  

^a Aristotle University Medical School   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5B; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1BETA; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; ATROPHY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY BIOPSY; KIDNEY NECROSIS; MACROPHAGE; MALE; OUTCOME ASSESSMENT; PARAMETER; PREDICTION; PROTEIN EXPRESSION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENOVASCULAR DISEASE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; C-REACTIVE PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3BETA1; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULITIS;

EID: 33751440538     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-7-16     Document Type: Article

References (29)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG: Nomenclature of systemic vasculitides: the proposal of an International Consensus Conference. Arthritis Rheum 1994, 37:187-192.
2. Kamesh L, Harper L, Savage COS: ANCA-positive vasculitis. J Am Soc Nephrol 2002, 13:1953-1960.
3. Cohen BA, Clark WF: Pauci-immune renal vasculitis: Natural history, prognostic factors and impact of therapy. J Am Soc Nephrol 2000, 36:. MEDLINE
4. Hogan S, Nachman P, Wilkman AS, Jennette JC, Falk RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996, 7:23-32.
5. Franssen CFM, Stegeman CA, Oost-Kort WW, kallenberg CG, Limburg PC, Tiebosch A, DeJong PE, Tervaert JW: Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 1998, 9:1915-1923.
6. Aasarod K, Bostad L, Hammerstrom J, Jorstad S, Iversen BM: Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. Nephrol Dial Transpl 2001, 16:953-960.
7. Hauer HA, Bajema IM, van Houwelingen, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS): Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transpl 2002, 17:587-596.
8. Hauer HA, Bajema IM, van Houwelingen, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS): Determinants of outcome in ANCA-associated GN: A prospective clinico-pathological analysis of 96 patients. Kidney Int 2002, 62:1732.
9. Savige J, Dimech W, Fritzler M: Addendum to the International Consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003, 120(3):312-318.
10. Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999, 56:1751-1758.
11. Jayne D, Rasmussen N: European collaborative trials in vasculitis: EUVAS update and latest results. Clin Exp Immunol 2000, 120(Suppl 1):13-15.
12. Couser WG: Pathogenetic mechanisms and treatment of rapidly progressive glomerulonephritis: Current concepts. Hellenic Nephrol 2002, 14(Suppl 1):22-26.
13. Striker LJ, Killen PD, Chi E, Striker GE: The composition of glomerulosclerosis. Lab Invest 1984, 51:181-192.
14. Foellmer HG, Sterzel RB, Kashgarian M: Progressive glomerular sclerosis in experimental antiglomerular basement membrane glomerulonephritis. Am J Kidney Dis 1986, 7:5-11.
15. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int 1998, 54:992-994.
16. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Garrtner HV: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1989, 31:67-76.
17. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y: Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000, 35(1):13-20.
18. Becker GJ, Hewitson TD: The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hyperten 2000, 9:133-138.
19. Harris D: ubulointerstitial renal disease. Curr Opin Nephrol Hypertens 2001, 10:303-313.
20. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 1999, 10:2323-2331.
21. Papagianni A: Cell-mediated immune mechanisms and the role of C5b-9 in idiopathic membranous nephropathy. In MD Thesis Thessaloniki, Greece; 1996.
22. Brandt J, Pippin J, Schulze M, Hansch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG: Role of the membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 1996, 49:335-343.
23. Hsu S, Couser WG: Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? J Am Soc Nephrol 2003, 14:S186-S191.
24. Adu D: . Clin Exp Immunol 1995, 101:62. abstract
25. Hogan S, Nachman P, Wilkman AS, Jennette JC, Falk RC: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996, 7:23-32.
26. Reinhold-Keller , De Groot K, Rudert H, Nolle B, Heller M, Gross WL: Sarcoidosis Vasc Diffuse Lung Dis 1996, 13:267. abstract
27. Franssen CFM, Stegeman CA, Kallenberg CGM, Gans RO, De Jong PE, Hoomtje SJ, Tervaert JW: Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000, 57:2195-2206.
28. Franssen CFM, Huitema MG, Muller Kobold AC, Oost-Kort WW, Limburg PC, Tiebosch A, Stegeman CA, kallenberg CG, Tervaert JW: In vitro neutrophil activation by antibodies to Proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis. Kidney Int 1999, 10:150-1515.
29. Harper L, Savage COS: Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000, 190:349-359.